Sort By: Date

    BioTelemetry, Inc. Enters Agreement to Provide Cardiac Monitoring for Apple’s Heart Study

    BioTelemetry, Inc. (NASDAQ:BEAT), the leading mobile and wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today a partnership with Apple (NASDAQ:AAPL) to provide cardiac monitoring services in conjunction with the Apple Heart Study.

    November 30, 2017

    BioTelemetry Research and AMRA Raise the Standard for Medical Imaging in NASH/NAFLD Clinical Trials

    BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced that BioTelemetry Research, their leading global imaging and cardiac core lab, and AMRA, the international leader in body composition analysis, have formed an exclusive alliance for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) clinical trials.

    October 25, 2017

    BioTelemetry, Inc. to Release Second Quarter 2017 Earnings Results on August 8, 2017

    BioTelemetry, Inc. (NASDAQ:BEAT) will release its second quarter 2017 earnings on Tuesday, August 8 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Tuesday, August 8, 2017. The broadcast will be available through the investor information section of the BioTelemetry website www.gobio.com.

    July 31, 2017

    BioTelemetry, Inc. Completes LifeWatch AG Acquisition

    BioTelemetry, Inc. (NASDAQ:BEAT), announced today it has completed its acquisition of LifeWatch AG (SIX:LIFE). “We are gratified that LifeWatch AG shareholders embraced the immense strategic value and potential of this acquisition and moved quickly to support the BioTelemetry tender,” said Joseph H. Capper, President and Chief Executive Officer of BioTelemetry, Inc.

    July 12, 2017

    BioTelemetry, Inc. Reaches a Final Milestone in Acquisition of LifeWatch AG

    BioTelemetry, Inc. (NASDAQ:BEAT), announced today the definitive results of the tender offer for LifeWatch AG (SIX:LIFE) which concluded on June 28, 2017. The definitive results show shareholders have tendered 17,848,661 shares of LifeWatch, representing approximately 97% of the total shares outstanding.

    July 7, 2017

    BioTelemetry, Inc. Reaches Key Milestone in Tender Offer for LifeWatch AG

    BioTelemetry, Inc. (NASDAQ:BEAT), announced today that during the main offer period which ended on June 8, 2017, the preliminary results show shareholders have tendered 15,161,925 shares of LifeWatch AG (SIX:LIFE), representing approximately 82% of the total shares outstanding.

    June 9, 2017

    Contact BioTelemetry

    General Inquiries

    Phone: 888.312.BEAT (2328)
    Fax: 610.828.8048

    Investors Information

    Contact: Heather Getz, CFO
    Phone: 800.908.7103
    InvestorRelations@biotelinc.com

    Media Inquiries

    Phone: 800.908.7103